Company intelligence / Profile preview

OncoAtlas

Ownership: Private
Development stage: Commercial

Overview

OncoAtlas provides full-stack precision oncology solutions including next-generation sequencing kits/panels and proprietary software for automated data analysis. Their products support routine clinical practice by enabling comprehensive genetic profiling of cancers to guide diagnosis and treatment selection. Their technology has replaced PCR-based genetic testing across large regions such as Siberia. They collaborate with researchers to expand access to advanced NGS-based cancer diagnostics.

Therapeutic areas: Oncology
Industry: Molecular Diagnostics

Partnerships

Collaborates with research institutions/labs

Beyond the preview

Go deeper on OncoAtlas.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OncoAtlas.

Explore the full profile